Serum amyloid A stimulates macrophage foam cell formation via lectin-like oxidized low-density lipoprotein receptor 1 upregulation

Biochemical and Biophysical Research Communications

Volumn 433, Issue 1, 2013, Pages 18-23

  Lee, Ha Young ^a,b   Kim, Sang Doo ^a   Baek, Suk Hwan ^c   Choi, Joon Hyuk ^c   Cho, Kyung Hyun ^d   Zabel, Brian A ^e   Bae, Yoe Sik ^a,b  

^a Sungkyunkwan University   (South Korea)

^b Dong A University   (South Korea)

^c Yeungnam University College of Medicine   (South Korea)

^d Yeungnam University   (South Korea)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Foam cell; Lectin like oxidized low density lipoprotein receptor 1; Serum amyloid A

Indexed keywords

HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; SERUM AMYLOID A; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; HUMAN; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ATHEROSCLEROSIS; CARRAGEENAN; CELL DIFFERENTIATION; CELL LINE; FOAM CELLS; HUMANS; LIPOPROTEINS, HDL; MAP KINASE SIGNALING SYSTEM; MICE; NF-KAPPA B; RECOMBINANT PROTEINS; SCAVENGER RECEPTORS, CLASS E; SERUM AMYLOID A PROTEIN; UP-REGULATION;

EID: 84875809836     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.02.077     Document Type: Article

References (41)

1. Li A.C., Glass C.K. The macrophage foam cell as a target for therapeutic intervention. Nat. Med. 2002, 8:1235-1242.
2. Valente A.J., Graves D.T., Vialle-Valentin C.E., Delgado R., Schwartz C.J. Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry 1988, 27:4162-4168.
3. Stanley E.R., Berg K.L., Einstein D.B., Lee P.S., Pixley F.J., Wang Y., Yeung Y.G. Biology and action of colony-stimulating factor-1. Mol. Repord. Dev. 1997, 46:4-10.
4. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809.
5. Cascieri M.A. The potential for novel anti-inflammatory therapies for coronary artery disease. Nat. Rev. Drug Discov. 2002, 1:122-130.
6. Rudijanto A. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med. Indones. 2007, 39:86-93.
7. Lusis A.J. Atherosclerosis. Nature 2000, 407:233-241.
8. Cao F., Castrillo A., Tontonoz P., Re F., Byme G.I. Chlamydia pneumobniae-induced macrophage foam cell formation is mediated by toll-like receptor 2. Infect. Immun. 2007, 75:753-759.
9. Funk J.L., Feingold K.R., Moser A.H., Grunfeld C. Lipopolysaccharide stimulation of RAW264.7 macrophages induces lipid accumulation and foam cell formation. Atherosclerosis 1993, 98:67-82.
10. Lee J.G., Lim E.J., Park D.W., Lee S.H., Kim J.R., Baek S.H. A combination of LOX-1 and Nox1 regulates TLR9-mediated foam cell formation. Cell. Signal. 2008, 20:2266-2275.
11. Uhlar C.M., Whitehead A.S. Serum amyloid A, the major vertebrate acute-phase reactat. Eur. J. Biochem. 1999, 265:501-523.
12. Jensen L.E., Whitehead A.S. Regulation of serum amyloid A protein expression during the acute-phase response. Biochem. J. 1988, 334:489-503.
13. Urieli-Shoval S., Linke R.P., Matzner Y. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr. Opin. Hematol. 2000, 7:64-69.
14. Koga T., Torigoshi T., Motokawa S., Miyashita T., Maeda Y., Nakamura M., Komori A., Aiba Y., Uemura T., Yatsuhashi H., Ishibashi H., Eguchi K., Migita K. Serum amyloid A-induced IL-6 production by rheumatoid synoviocytes. FEBS Lett. 2008, 582:579-585.
15. Jijon H.B., Madsen K.L., Walker J.W., Allard B., Jobin C. Serum amyloid A activates NF-kappaB and proinflammatory gene expression in human and murine intestinal epithelial cells. Eur. J. Immunol. 2005, 35:718-726.
16. Furlaneto C.J., Campa A. A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil. Biochem. Biophys. Res. Commun. 2000, 268:405-408.
17. Malle E., Steinmetz A., Raynes J.G. Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis 1993, 102:131-146.
18. Lee H.Y., Kim S.D., Shim J.W., Lee S.Y., Lee H., Cho K.H., Yun J., Bae Y.S. Serum amyloid A induces CCL2 production via formyl peptide receptor-like 1-mediated signaling in human monocytes. J. Immunol. 2008, 81:4332-4339.
19. Lee H.Y., Kim M.K., Park K.S., Bae Y.H., Yun J., Park J.I., Kwak J.Y., Bae Y.S. Serum amyloid A stimulates matrix-metalloproteinase-9 upregulation via formyl peptide receptor like-1-mediated signaling in human monocytic cells. Biochem. Biophys. Res. Commun. 2005, 330:989-998.
20. Lee H.Y., Kim S.D., Shim J.W., Yun J., Kim K., Bae Y.S. Activation of formyl peptide receptor like-1 by serum amyloid A induces CCL2 production in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 2009, 380:313-317.
21. Lee H.Y., Kim S.D., Shim J.W., Kim H.J., Yun J., Baek S.H., Kim K., Bae Y.S. A pertussis toxin sensitive G-protein-independent pathway is involved in serum amyloid A-induced formyl peptide receptor 2-mediated CCL2 production. Exp. Mol. Med. 2010, 42:302-309.
22. Glurich I., Grossi S., Albini B., Ho A., Shah R., Zeid M., Baumann H., Genco R.J., De Nardin E. Systemic inflammation in cardiovascular and periodontal disease: comparative study. Clin. Diagn. Lab. Immunol. 2002, 9:425-432.
23. Lewis K.E., Kirk E.A., McDonald T.O., Wang S., Wight T.N., O'Brien K.D., Chait A. Increase in serum amyloid A evoked by dietary cholesterol is associated with increased atherosclerosis in mice. Circulation 2004, 110:540-545.
24. Cho K.H., Jonas A. A key point mutation (V156E) affects the structure and functions of human apolipoprotein A-1. J. Biol. Chem. 2000, 275:26821-26827.
25. Han J.M., Jeong T.S., Lee W.S., Choi I., Cho K.H. Structural and functional properties of V156K and A158E mutants of apolipiprotein A-1 in the lipid-free and lipid-bound state. J. Lipid Res. 2005, 46:589-596.
26. Kataoka H., Kume N., Miyamoto S., Minami M., Moriwaki H., Murase T., Sawamura T., Masaki T., Hashimoto N., Kita T. Expression of lectin-like oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 1999, 99:3110-3117.
27. Hermonat P.L., Zhu H., Cao M., Mehta J.L. LOX-1 transcription. Cardiovasc. Drugs Ther. 2011, 25:393-400.
28. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298:1911-1912.
29. Wang J., An F.S., Zhang W., Gong L., Wei S.J., Qin W.D., Wang X.P., Zhao Y.X., Zhang Y., Zhang C., Zhang M.X. Inhibition of c-Jun N-terminal kinase attenuates low shear stress-induced atherogenesis in apolipoprotein E-deficient mice. Mol. Med. 2011, 17:990-999.
30. Yang C.M., Luo S.F., Hsieh H.L., Chi P.L., Lin C.C., Wu C.C., Hsiao L.D. Interleukin-1beta induces ICAM-1 expression enhancing leukocyte adhesion in human rheumatoid arthritis synovial fibroblasts: involvement of ERK, JNK, AP-1, and NF-kappaB. J. Cell Physiol. 2010, 224:516-526.
31. Abbas A., Fadel P.J., Wang Z., Arbique D., Jialal I., Vongpatanasin W. Contrasting effects of oral versus transdermal estrogen on serum amyloid A (SAA) and high-density lipoprotein-SAA in postmenopausal women. Arterioscler. Thromb. Vasc. Biol. 2004, 24:e164-e167.
32. Fyfe A.I., Rothenberg L.S., DeBeer F.C., Cantor R.M., Rotter J.I., Lusis A.J. Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes. Circulation 1997, 96:2914-2919.
33. Miller Y.I., Choi S.H., Fang L., Tsimikas S. Lipoprotein modification and macrophage uptake: role of pathologic cholesterol transport in atherogenesis. Subcell. Biochem. 2010, 51:229-251.
34. Endemann G., Stanton L.W., Maden K.S., Bryant C.M., White R.T., Protter A.A. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 1993, 268:11811-11816.
35. Suzuki H., Kurihara Y., Takeya M., Kamada N., Kataoka M., Jishage K., Ueda O., Sakaguchi H., Higashi T., Suzuki T., Takashima Y., Kawabe Y., Cynshi O., Wada Y., Honda M., Kurihara H., Aburatani H., Doi T., Matsumoto A., Azuma S., Noda T., Toyoda Y., Itakura H., Yazaki Y., Kodama T., et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 1997, 386:292-296.
36. Liang M., Zhang P., Fu J. Up-regulation of LOX-1 expression by TNF-alpha promotes trans-endothelial migration of MDA-MB-231 breast cancer cells. Cancer Lett. 2007, 258:31-37.
37. Taront S., Dieudonné A., Blanchard S., Jeannin P., Lassalle P., Delneste Y., Gosset P. Implication of scavenger receptors in the interactions between diesel exhaust particles and immature or mature dendritic cells. Part. Fibre. Toxicol. 2009, 6:9-22.
38. Doyle S.E., O'Connell R.M., Miranda G.A., Vaidya S.A., Chow E.K., Liu P.T., Suzuki S., Suzuki N., Modlin R.L., Yeh W.C., Lane T.F., Cheng G. Toll-like receptors induce a phagocytic gene program through p38. J. Exp. Med. 2004, 199:81-90.
39. Wang H.Y., Qu P., Lu S., Liu M., Jiang H. The effect of TLR4/NF-kappaB activation and LOX-1 on monocyte adhesion to endothelium. Zhonghua Xin Xue Guan Bing Za Zhi 2005, 33:827-837.
40. Nandi S., Ma L., Denis M., Karwatsky J., Li Z., Jiang X.C., Zha X. ABCA1-mediated cholesterol efflux generates microparticles in addition to HDL through processes governed by membrane rigidity. J. Lipid Res. 2009, 50:456-466.
41. Dufton N., Hannon R., Brancaleone V., Dalli J., Patel H.B., Gray M., D'Acquisto F., Buckingham J.C., Perretti M., Flower R.J. Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation. J. Immunol. 2010, 184:2611-2619.